Correlation Between Fubon MSCI and Taigen Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and Taigen Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and Taigen Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fubon MSCI Taiwan and Taigen Biopharmaceuticals Holdings, you can compare the effects of market volatilities on Fubon MSCI and Taigen Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of Taigen Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and Taigen Biopharmaceutica.

Diversification Opportunities for Fubon MSCI and Taigen Biopharmaceutica

-0.36

Correlation Coefficient

Fubon MSCI  Taigen Biopharmaceutica

Very good diversification

The 3 months correlation between Fubon and Taigen is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and Taigen Biopharmaceuticals Hold in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taigen Biopharmaceutica and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with Taigen Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taigen Biopharmaceutica has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and Taigen Biopharmaceutica go up and down completely randomly.

Pair Corralation between Fubon MSCI and Taigen Biopharmaceutica

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 0.79 times more return on investment than Taigen Biopharmaceutica. However, Fubon MSCI Taiwan is 1.27 times less risky than Taigen Biopharmaceutica. It trades about 0.11 of its potential returns per unit of risk. Taigen Biopharmaceuticals Holdings is currently generating about -0.23 per unit of risk. If you would invest  13,240  in Fubon MSCI Taiwan on September 16, 2024 and sell it today you would earn a total of  1,125  from holding Fubon MSCI Taiwan or generate 8.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fubon MSCI Taiwan  vs.  Taigen Biopharmaceuticals Hold

Fubon MSCI Taiwan

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Fubon MSCI may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Taigen Biopharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Fubon MSCI and Taigen Biopharmaceutica

The main advantage of trading using opposite Fubon MSCI and Taigen Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, Taigen Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taigen Biopharmaceutica will offset losses from the drop in Taigen Biopharmaceutica's long position.

The idea behind Fubon MSCI Taiwan and Taigen Biopharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.